Cabrera-Rayo A, Nellen-Hummel H

Language: Spanish
References: 12
Page: 3-5
PDF size: 38.37 Kb.

ABSTRACT

Venous thromboembolic disease (VTD) encompasses two main pathological states: deep vein thrombosis (DVT) and pulmonary thromboembolism (PT). Despite improvement in prophylaxis, diagnosis, and treatment of VTD it still represents an unacceptable cause of high levels of morbidity and mortality in ambulatory and in-hospital patients. Incidence of DVT reaches 1 case/10,000 young adults through 1 case/100 senior adults. In people older than 65 to 69 year-old incidence rises from 1.8 cases/1,000 habitants/year up to 3.1 cases/1,000 habitants/year after 85 years-old. In Mexico, it was informed that in a general hospital incidence of PT was 15%, similar for both genders and predominantly affecting patients between 60 and 80 years-old. In another Mexican institution, PT was the third most frequent cause of mortality. It is well known that DVP almost always precedes PT although this last appears almost always following an asymptomatic DVT. Most information about VTD comes from surgical studies; however it is also an important problem in Internal Medicine patients. Today, it has been proved that pharmacological thromboprophylaxis indicated in Internal Medicine departments, significantly diminishes the incidence of VTD. It is crucial to consider that most epidemiological studies have been performed in a very few countries, using different classifications and diagnostic criteria. Physicians should be aware of possible misconceptions about this body of information. Therefore, it is necessary to investigate in every country the local epidemiology of VTD.

REFERENCES

1. Geerts WH, Heit JA, Claget GP, Pineo GF, Colwell CW, Anderson FA, et al. Prevention of venous thromboembolism. Chest 2001;119:132S–175S.

2. Spyropoulus AC. Emerging strategies in the prevention of venous thromboembolism in hospitalized medical patients. Chest 2005;118:958-969.

3. Carson JS, Kelley MA, Duff A, Weg JG, Fulkerson WJ, Palevsky HI, et al. The clinical course of pulmonary embolism. N Engl J Med 1992;326:1240-1245.

4. Sigler L, Romero T, Meillón LA, Gutiérrez L, Aguirre GJ, Esparza C. Tromboembolia pulmonar en un período de 10 años. Rev Med IMSS 1996;34:7-11.

5. Sandoval ZJ, Martínez GML, Gómez A, Palomar A, Pulido T, Zevallos M. PAC Cardio-1. Tromboembolia pulmonar aguda. Sociedad Mexicana de Cardiología. Editorial Intersistemas, México, DF. 1998;7-9.

6. Monreal M, Kakkar AK, Capriani JA, Barba R, Uresandi F, Valle R, et al. for the RIETE investigators. Is the natural history of venous thromboembolism different in surgery and non-surgery patients? Findings from the RIETE registry. Blood 2003;102:112b.

7. Alikhan R, Cohen AT, Combe S, Samama M, Desjardins L, Eldor A, et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illnes: Analysis of the MEDENOX Study. Arch Intern Med 2004;164:963-968

8. Cade JF. High risk of the critically ill for venous thromboembolism. Crit Care Med 1982;10:448-450.

9. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients. Are we detecting enough deep vein thrombosis? J R Soc Med 1989;82:203-205.

10. Marik PE, Andrews L, Maini B. The incidence of deep venous thrombosis in ICU patients. Chest 1997;111:661-664.

11. Cook D, Crowther M, Meade M, Rabbat C, Griffith L, Schiff D, et al. Deep venous thrombosis in medical-surgery critically ill patients: Prevalence, incidence and risk factors. Crit Care Med 2005;33:1565-1571.

12. Geerts WH, Pineo GF, Heit JA, Bergquist D, Lassen MR, Colwell CW, et al. Prevention of venous thromboembolism. Chest 2004;126:338S-400S.